loader image

Cutting down
patient wait times
for innovative treatments​

Member of the Swiss Biotech Association logo



of 1st time launcher deliver below expectation

Realize the value of a clinical program into real-life setting

Why a Market-Entry accelerator?

Completing a clinical program is a fantastic achievement, but that does not guarantee access to patients. The ability to deploy commercially is a key part of the value of a biopharma asset. Regulators, Payers, Physicians and patients need to align behind the medical value. A commercial venture requires very different muscles than those of drug development. It is not a risk-free endeavor and must start well ahead of approval.

A Market-Entry accelerator is a perfect fit to find the the way to patients and to morph a clinical-stage organization into a launch-ready organization

When insider advice meets deep-tech

What does xcube offer?

Securing the right advisory is crucial to kickstarting a successful commercial journey, but it’s just the beginning. To reach patients rapidly, you need precise decision-making, dedicated financing, and flawless execution within a high-performing launch ecosystem. At Xcube.bio, we leverage targeted deep-tech to facilitate patient access to groundbreaking biopharma innovations.​

Fast-track the path to patients, empower your launch plan, and optimize costs with Xcube.bio’s integrated platform

Decision support

Bridge management

Expansion equity

Expansion equity

Organization ecosystem

Deep-tech ecosystem


Going through the risky entry period through flexible partnering​

How xcube.bio works?

Xcube.bio operates on the premise that each partner brings unique strengths to the commercial venture. No one is in a better position than a biopharma innovator to lead the science, medicine, and product manufacturing. Xcube.bio provides market insights, equity, and commercial enablers. The partnership builds progressively, starting with light-touch and flexible advisory services for initial commercial decisions upon Phase II, and evolves into a co-managed entity to navigate the market launch.

Xcube.bio develops a “build together” partnership that keeps the biopharma innovator in control of their asset with a favorable risk/benefit balance.

Hands-on and invested in the mission.

Who are we?

Xcube.bio comprises a diverse team of hands-on industry experts catering to innovators’ needs: from launch and market access experts to organization builders and supply chain advisors, and from medical to financial capabilities.

We have already succeeded in what we offer within biopharma organizations.

Pierre-Henri (PH) Belin
Ludo Ooms
Jan Boelher
Kriti Sharma
Marine Baxendell

Let’s start the conversation​

How to connect?

There is so much more we can share and so many solutions to explore. Let’s schedule a touch point to discuss your ambition.